Recurrent Cervical Adenocarcinoma
1 clinical trials · Condition
◉ Watch Recurrent Cervical Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers (NCT03452332) | M.D. Anderson Cancer Center | 2018-07-18 |
Track Recurrent Cervical Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.